NCT03074786View on ClinicalTrials.gov

Reversing the Epidemic in Africa With Choices in HIV Prevention (REACH)

PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

November 30, 2017

Primary Completion Date

December 31, 2018

Study Completion Date

December 30, 2020

Conditions

HIV-1-infection

Interventions

DRUG

Dapivirine

Silicone elastomer vaginal matrix ring

DRUG

Truvada

Tablets to be taken orally daily

Trial Locations (1)

Unknown

CAPRISA, eThekwini Clinical Research Site, Durban

Sponsors

Collaborators (1)

Gilead Sciences

All Listed Sponsors

collaborator

Gilead Sciences

INDUSTRY

lead

International Partnership for Microbicides, Inc.

INDUSTRY